Customer Facing Medical Manager HIV, BeLux - Medical Affairs at Gilead Sciences

Brussels, Brussels, Belgium

Gilead Sciences Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Healthcare, BiotechnologyIndustries

Requirements

  • Strong biomedical background with relevant medical knowledge
  • Strategic thinking, communication skills, business acumen, and enterprise mindset
  • Ability to lead medical affairs activities in HIV and contribute to cross-functional projects
  • Dedication of at least 50% of time to customer-facing field activities (meetings, presentations, congresses)
  • Compliance with pharmaceutical regulations and laws, expertise in drug safety and medical topics
  • Ability to develop medical product information and stay informed on scientific trends and competition

Responsibilities

  • Provide medical support to cross-functional teams in the affiliate within the HIV therapeutic area
  • Liaise with key opinion leaders (KOLs) and healthcare professionals in academic and clinical centres for scientific exchange and data generation
  • Establish and maintain relationships with opinion leaders, payers, clinical investigators, providers, and relevant non-governmental organizations
  • Maintain and update a country opinion leaders (OL) list twice yearly
  • Drive discussions and projects to integrate scientific data into clinical decision making for patient benefit
  • Identify and collaborate with local experts on local data generation activities
  • Assist with pipeline activities, liaise with Clinical Operations, and support site selection for Phase IV and other clinical trials
  • Support preparation of scientific presentations and speaker briefings during scientific meetings/medical education events
  • Ensure accuracy of data to support existing products or new product launches
  • Ensure Gilead’s medical affairs activities comply with pharmaceutical regulations and laws

Skills

Medical Affairs
HIV
Virology
Biomedical
Strategic Thinking
Cross-functional Collaboration
Communication Skills
Business Acumen

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI